Yoshihito Horisawa
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice.
Journal: Cancer reports (Hoboken, N.J.)
Published: September 27, 2024
Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice.
Journal: Communications medicine
Published: May 05, 2022
Pharmacologic characterization of TBP1901, a prodrug form of aglycone curcumin, and CRISPR-Cas9 screen for therapeutic targets of aglycone curcumin.
Journal: European journal of pharmacology
Published: April 25, 2022
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance.
Journal: Cell reports
Published: August 30, 2021
ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells.
Journal: Scientific reports
Published: July 27, 2021
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
Journal: Nature
Published: July 22, 2021
APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
Journal: Biochemical and biophysical research communications
Published: January 06, 2021
A case of allogeneic hematopoietic stem cell transplantation for primary plasma cell leukemia after treatment with daratumumab.
Journal: Annals of hematology
Published: March 03, 2020
Essential thrombocythemia accompanied by adrenal infarction
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 08, 2019
Substantial Improvement in a Nerve Conduction Study of Lymphoma-associated Demyelinating Neuropathy Treated by Intravenous Immunoglobulin and Chemotherapy.
Journal: Internal medicine (Tokyo, Japan)
Published: August 14, 2018
Last Updated: 09/26/2026